Mon–Thu 8–18, Fri 8–16
Imaging studies and tissue samples play an important role in breast cancer diagnosis and treatment planning. The quality of the examinations is guaranteed by the state-of-the-art equipment and the experience of the staff.
The diagnosis stage starts with an appointment with an oncology specialist, who recommends further examinations if necessary.
After the initial clinical examination accomplished by the oncologist, typically mammography, ultrasound examination and ultrasound guided needle biopsy follow if there is a reason to suspect breast cancer. If needed, needle biopsy may also be taken from suspicious lymph nodes. If the cancer suspicion still exists after the fore mentioned, a typical next step is to perform MRI (magnetic resonance imaging), which is the most sensitive method in breast cancer diagnosis.
If the patient has breast cancer, it is important to create as accurate understanding of the stage of the cancer as possible before a final surgery decision is made. MRI may reveal more cancer than the previous examinations have shown. This information is essential for proper treatment plan.
The biopsies can also be utilized for example in detecting HER2 expression or sensitivity to hormones already before the surgery.
At Docrates Cancer Center you get imaging examinations quickly and easily with a specialist’s referral.
If you don’t have a referral, you can make an appointment for a specialist at Docrates. You get the time quickly in few days at its best. The oncologist assesses your situation and if further examinations, like imaging, are required, the doctor gives you a referral. Where possible, the imaging examinations are arranged for the same day.
If you have a suspicion of a breast cancer or you have received a diagnosis lately, you get specialist’s reception time quickly and without a referral at Docrates Cancer Center. Contact us. Our nurses will serve you with years of experience.
New forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...
Read more
With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....
Breast cancer is a serious disease that requires individual care and expertise. As part of cancer treatment, the patient may...
Contact us!
Mon-Thu 8:00-18:00, Fri 8:00-16:00
